What Is an FDA Customs Clearance Consultant?
An FDA customs clearance consultant is a licensed customs broker or regulatory specialist who manages the U.S. entry process for goods regulated by the Food and Drug Administration — including food, drugs, medical devices, cosmetics, and biologics. Getting regulated imports through customs requires more than standard entry filing; it requires coordinating two federal agencies, managing product-specific documentation, and responding quickly when the FDA flags a shipment for review or detention.
For importers unfamiliar with FDA requirements, a single compliance gap can hold an entire shipment at the port, trigger an import alert, or result in a refusal of admission that bars future entries of the same product.
FDA-regulated import: Any commercial shipment entering the United States that contains a product under FDA jurisdiction — defined broadly in 21 USC 321 and enforced at the border by CBP acting under authority delegated by the FDA. This covers roughly 20% of all U.S. consumer goods by value, including an estimated $93 billion in imported food and $100 billion in imported medical products annually.
Which Products Require FDA Clearance?
Before hiring a consultant, importers need to confirm whether their product falls under FDA jurisdiction. The FDA regulates a wider range of goods than most importers expect.
| Product Category | FDA Program | Key Requirement |
|---|---|---|
| Human food & beverages | CFSAN — import program | Prior Notice (21 CFR Part 1, Subpart I) |
| Dietary supplements | CFSAN | Prior Notice + labeling compliance |
| Prescription & OTC drugs | CDER | Drug establishment registration |
| Medical devices | CDRH | Device listing, 510(k) or PMA clearance |
| Cosmetics | CFSAN | No pre-clearance; labeling and ingredient compliance |
| Biologics & vaccines | CBER | Biologics license application |
| Tobacco products | CTP | Premarket authorization or substantial equivalence |
| Animal food & feed | CVM | Prior Notice required for animal food |
| Radiation-emitting devices | CDRH | Performance standards under 21 CFR Part 1020 |
If your product appears in this table, you are subject to FDA import oversight every time a shipment crosses the U.S. border. A customs broker with FDA experience — or a dedicated FDA customs clearance consultant — is not optional in these categories; it is a practical necessity.
You can browse brokers by specialty at CustomsBrokerIndex.com to find brokers who specifically handle pharmaceutical, food, and other regulated import categories.
How the FDA Customs Clearance Process Works
The FDA does not operate its own inspection lanes. Instead, it works through CBP’s Automated Commercial Environment (ACE) system to screen, select, and act on entries for regulated products. Here is how the process flows from shipment departure to cargo release.
Step 1: Advance Filing and Prior Notice
For food, dietary supplements, and animal feed, the importer or their consultant must submit Prior Notice through the FDA’s Prior Notice System Interface (PNSI) or through ACE before the shipment arrives. Submission windows depend on mode of transport: 8 hours before arrival for air shipments, 2 hours for land shipments, and 8 hours (up to 5 days in advance) for sea shipments under 21 CFR Part 1, Subpart I.
The Prior Notice record must include the FDA product code, shipper information, country of origin, anticipated arrival port, and the name of the submitter. Errors in any field can trigger an automatic hold.
Step 2: Entry Filing in ACE
The customs broker files the formal entry in ACE, which routes the data to CBP and simultaneously alerts the FDA’s Operational and Administrative System for Import Support (OASIS). OASIS cross-references the product, manufacturer, and country against FDA’s databases — including the Import Alert list, establishment registrations, and prior compliance history.
At this stage, the consultant ensures the correct FDA product code is paired with the right HTS code from the Harmonized Tariff Schedule. Mismatches between the two are a common trigger for FDA holds.
Step 3: FDA Screening Decision
Within hours of entry filing, OASIS returns one of three outcomes:
- May Proceed — The shipment is cleared for release without FDA examination. This is the outcome for the large majority of entries.
- Exam — CBP holds the shipment for physical inspection, sampling, or documentary review at the direction of the FDA.
- Detention Without Physical Examination (DWPE) — The shipment is held under an active Import Alert. The importer must provide evidence of admissibility before the FDA will release the goods.
Step 4: Responding to Holds and Examinations
If the FDA selects a shipment for exam, the consultant coordinates with the examining officer, arranges laboratory testing when required, prepares the response to FDA’s Notice of Action (FDA Form 2709), and submits supporting documentation including labeling samples, certificates of analysis, or manufacturer audit records.
Response deadlines are strict. If the importer fails to respond within the required window — typically 10 working days under 21 CFR Part 1 — the FDA issues a Notice of Refusal of Admission.
Step 5: Release or Refusal
If the FDA accepts the importer’s documentation, it issues a release and cargo proceeds to the final destination. If the FDA refuses admission, the importer must either re-export or destroy the goods under CBP supervision. The cost of destruction or re-export is borne entirely by the importer.
The Regulatory Framework: Key Citations
Understanding the legal basis for FDA import enforcement helps importers know what they are actually required to do — and what a consultant is protecting them from.
21 USC 381 is the primary statute governing FDA import admissibility. It grants the FDA authority to refuse admission to any article that appears to be in violation of U.S. law — including adulteration, misbranding, or lack of required registration.
21 CFR Part 1, Subpart I covers Prior Notice requirements for food under the Bioterrorism Act of 2002. Failure to submit Prior Notice is itself grounds for refusal under 21 USC 381(m).
21 CFR Part 820 (Quality System Regulation) governs medical device manufacturing standards. CBP uses device listing data from the FDA’s device establishment database to verify that foreign manufacturers are registered before releasing shipments.
19 CFR Part 141 governs the formal entry process and the importer of record’s obligations under CBP. The customs broker files on behalf of the importer of record, who remains legally responsible for the accuracy of all entry data under 19 USC 1484.
Importers can search for FDA and CBP guidance documents at CBP.gov and check prior agency rulings relevant to their product classification at rulings.cbp.gov.
Real-World Scenarios: When a Consultant Makes the Difference
Scenario 1: First-Time Food Importer
A small specialty food company imports olive oil from a producer in Spain. Their first two shipments clear without issue. On their third shipment, OASIS flags the entry because the foreign facility’s FDA registration has lapsed — a requirement under 21 USC 350d that renews every two years during even-numbered years. Without a consultant, the importer has no idea why the shipment is held or how to resolve it. A consultant recognizes the issue immediately, contacts the foreign supplier, facilitates re-registration, and submits the updated registration number to the FDA examiner — typically resolving the hold within 24 to 48 hours.
Scenario 2: Medical Device Import Alert
A U.S. distributor sources Class II medical devices from a manufacturer in China. The manufacturer appears on FDA Import Alert 89-08, which covers devices from manufacturers with significant violations. The importer does not discover this until goods have already shipped. A consultant familiar with the Import Alert system advises the importer on their options: they can request voluntary admissibility sampling (paying for laboratory testing to demonstrate the product meets standards) or arrange re-export before incurring destruction costs. Without early intervention, the importer risks automatic refusal and a permanent record affecting future entries of the same product.
Scenario 3: Dietary Supplement Labeling
An e-commerce seller imports a private-label protein powder from a contract manufacturer in Canada. The supplement contains a new dietary ingredient (NDI) that requires a premarket notification to the FDA under 21 CFR Part 190. The importer’s standard customs broker files the entry correctly but does not flag the NDI issue. The FDA detains the shipment and issues a notice requesting proof of NDI notification. An FDA-specialist consultant steps in, audits the product formula, identifies the specific ingredient, and prepares a submission to FDA’s CFSAN office — a process that takes 3 to 4 weeks and costs significantly more than proactive compliance would have.
Common Mistakes Importers Make With FDA Entries
Assuming a general customs broker covers FDA requirements. A licensed customs broker can file any entry, but FDA-regulated entries require knowledge of product codes, facility registration, Prior Notice procedures, and Import Alert databases that many general brokers do not maintain. Always confirm that your broker has active experience with your specific product category.
Submitting Prior Notice after the ship departs. The submission window for Prior Notice closes at the arrival deadline, not at the time of entry filing. Shipments arriving without a valid Prior Notice on file are subject to mandatory hold and potential refusal under 21 CFR Part 1.
Using the wrong FDA product code. FDA product codes are a separate classification system from HTS codes. Selecting an incorrect code — even a close one — routes your entry to the wrong FDA review queue, causes unnecessary exam selection, and can delay release by days. The FDA maintains a product code database at FDA.gov that a consultant should reference for every entry.
Ignoring import alert status of foreign suppliers. Before placing a purchase order with a new foreign supplier, importers should check FDA’s import alert database. Goods from a supplier on an active import alert face Detention Without Physical Examination on arrival, regardless of the product’s actual condition.
Underestimating re-labeling requirements. Many imported food and supplement products require English-language labeling compliant with 21 CFR Part 101 before entry. Bringing products in with foreign-language-only labels is a misbranding violation and grounds for refusal.
You can search all CBP-licensed customs brokers at CustomsBrokerIndex.com to find brokers with verified credentials and specialty experience in FDA-regulated imports.
Tools and Resources for FDA Import Compliance
| Tool | Purpose | URL |
|---|---|---|
| FDA Prior Notice System Interface (PNSI) | Submit Prior Notice for food imports | accessible via FDA.gov |
| ACE Secure Data Portal | File formal entries; manage FDA routing | CBP.gov |
| FDA Import Alerts database | Check supplier alert status before ordering | FDA.gov/importalerts |
| FDA Establishment Registration | Verify foreign facility registration | FDA.gov |
| CBP Binding Rulings | Get advance classification guidance | rulings.cbp.gov |
| HTS Online | Identify correct tariff classification | hts.usitc.gov |
| NCBFAA Member Directory | Find licensed customs brokers | ncbfaa.org |
| CustomsBrokerIndex.com | Find FDA-specialist brokers by port or state | customsbrokerindex.com |
For importers entering FDA-regulated goods at specific U.S. ports — Los Angeles/Long Beach, Miami, New York/Newark, Chicago O’Hare — finding a broker with on-the-ground experience at that facility matters. You can browse by U.S. port of entry to narrow your search by arrival location.
The National Customs Brokers & Forwarders Association of America (NCBFAA) also maintains a member directory and offers continuing education resources for brokers specializing in FDA compliance.
For related context on how customs clearance fits into broader logistics operations, see our guide to 3PL with customs clearance and warehousing.
Frequently Asked Questions
What is an FDA customs clearance consultant?
An FDA customs clearance consultant is a licensed customs broker or regulatory specialist who manages the entry process for goods subject to FDA oversight — including foods, drugs, medical devices, cosmetics, and biologics. They coordinate between CBP, the FDA, and the importer to ensure shipments meet all applicable federal requirements before release.
How does the FDA customs clearance process work?
When a regulated shipment arrives at a U.S. port, CBP electronically routes the entry to the FDA for review via the Automated Commercial Environment (ACE). The FDA examines entry documents, Prior Notice filings, and product data. It may issue a “May Proceed” for automatic release, select the shipment for documentary review, or detain the goods for physical examination. A consultant manages each of these stages and responds to any FDA requests.
Who needs an FDA customs clearance consultant?
Any importer bringing in FDA-regulated products — food, dietary supplements, pharmaceuticals, medical devices, cosmetics, tobacco, or biologics — benefits from a consultant. The need becomes critical when importing high-risk commodities, dealing with an import alert, responding to a detention or refusal, or expanding into regulated categories for the first time.
What does an FDA customs clearance consultant cost?
Costs vary by product type and complexity. Basic entry filing fees range from $150 to $400 per shipment. FDA-regulated entries add $75 to $250 in specialized handling fees. If a shipment is detained, consultant fees for preparing a formal response or requesting admissibility sampling can run $500 to $2,500 or more, depending on the scope of documentation required.
What is the most common mistake importers make with FDA entries?
The most common mistake is missing or late Prior Notice for food shipments. Under 21 CFR Part 1, Sub